ALDOA and neoplasm: Furthermore, immune checkpoint analysis revealed that ALDOA-high tumors exhibit reduced expression of key immune checkpoints, including PDCD1, CTLA4, and TIGIT, potentially reducing immune cell engagement with the tumor and further promoting immune evasion.